Business
Shanghai Jiuchuan will pay $130 million for 100% of SHL Telemedicine's shares.
Hi, what are you looking for?
Shanghai Jiuchuan will pay $130 million for 100% of SHL Telemedicine's shares.
The deal, the largest ever acquisition by an Israeli company, is in cash and shares.
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the...
The groups told the US FTC: Increased consolidation has already led to higher prices and to generic drug shortages.
– – Israel’s ReWalk Robotics Ltd. (Nasdaq: RWLK), an exoskeleton manufacturer, unveiled the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking...
Teva is the first applicant to receive approval and will have market exclusivity for generic Axert until November.
As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food...
Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50 million Investment and Licensing Deal in China
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”